Q32 Bio Inc. (QTTB)
NASDAQ·Healthcare·Biotechnology
$5.79
+5.85%
Mkt Cap $65.58M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 10, 2026 | $53.74M | $53.74M | +0.00% | -$0.85 | $3.65 | +529.41% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$1.39 | -$0.60 | +56.83% | — | — |
| Q3 2025 Aug 6, 2025 | — | — | — | -$1.14 | -$0.78 | +31.58% | — | — |
| Q2 2025 May 8, 2025 | — | — | — | -$1.23 | -$0.90 | +26.83% | — | — |
| Q1 2025 Mar 11, 2025 | — | — | — | -$1.25 | -$1.16 | +7.20% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$1.41 | -$1.46 | -3.55% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$1.00 | -$1.42 | -42.00% | — | — |
| Q2 2024 May 9, 2024 | $170.00K | — | — | -$1.42 | -$13.15 | -826.06% | — | — |
| Q1 2024 Mar 13, 2024 | $500.00K | -$14.66M | -3032.40% | -$0.30 | -$0.28 | +6.67% | — | — |
| Q4 2023 Nov 14, 2023 | $500.00K | $1.86M | +271.80% | -$0.42 | -$0.57 | -35.71% | — | — |
| Q3 2023 Jul 27, 2023 | $830.50K | $354.00K | -57.38% | -$8.55 | -$10.98 | -28.42% | — | — |
| Q1 2023 Mar 30, 2023 | $1.01M | $802.00K | -20.95% | -$9.54 | -$9.00 | +5.71% | — | — |
| Q4 2022 Dec 30, 2022 | $830.60K | $802.00K | -3.44% | -$8.86 | -$10.74 | -21.21% | — | — |
| Q3 2022 Sep 29, 2022 | $860.60K | $802.00K | -6.81% | -$8.21 | -$10.57 | -28.64% | — | — |
| Q2 2022 Jun 29, 2022 | $1.00M | $802.00K | -19.88% | -$9.68 | -$9.12 | +5.70% | — | — |
| Q1 2022 Mar 30, 2022 | — | $802.00K | — | — | $28.65 | — | — | — |
| Q4 2021 Dec 30, 2021 | $7.21M | $802.00K | -88.87% | -$8.87 | -$10.58 | -19.28% | — | — |
| Q3 2021 Sep 29, 2021 | — | $1.68M | — | — | -$9.65 | — | — | — |
| Q2 2021 Jun 29, 2021 | — | $2.19M | — | — | -$9.72 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $29.30M | — | — | -$0.38 | — | — | — |